Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 1998

View Archived Issues

Genentech: FY 1997 highlights

CellPro: Q3 1998 highlights

Isis Pharmaceuticals: Q4 and FY 1997 highlights

Ilex Oncology: Q4 and FY 1997 highlights

Guilford: FY 1997 highlights

Substance P antagonists revealed by Boehringer Ingelheim

Tyrosine kinase modulators under development by Yissum, Sugen

Merck describes dopamine D4 receptor ligands with therapeutic potential

A novel NOS inhibitor possibly involved in elevating arterial pressure

Antimetastatic properties of ND-2001, a nojirimycin derivative

Diversa identifies new therapeutic leads on the ocean floor

SKB and WHO join forces to wipe out lymphatic filariasis

Founding of new German biotech company announced

Cubist outlines development plans for daptomycin

Olopatadine still under regulatory review in Japan

Novel VEGF inhibitors in development at Genentech

Small-molecule chemokine receptor antagonists from Teijin

Klinge discovers compounds for asthma with high efficacy and safety

New antiproliferative compounds patented by Warner-Lambert

Tsetse thrombin inhibitor isolated, purified and characterized at Yale

KY-62 evaluated in murine models of candidiasis

New HRT option now available for Canadian women

Centocor to acquire rights to reteplase in U.S., Canada

Selective inhibition of HIV integrase by dicaffeoylquinic and dicaffeoyltartaric acids

SBIR grant goes to OSI for diabetes research

New once-daily antihypertensive combination available in U.S.

Meridian and Duoject to jointly develop innovative drug delivery system

New hope for patients diagnosed with malignant pleural effusions

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...